11/18/2023 0 Comments Agena bioscience careersPrior to DPI he served as Division Manager of the Analytical Systems Division of Bio-Rad Laboratories. Before founding Nexus, John served as CTO for Discovery Partners International (DPI) and VP/GM of DPI’s Systems Division. Prior to Brooks, John was the Founder, Chairman, President, CEO of Nexus Biosystems. Before Agena, John served as Senior VP and Managing Director of the Brooks Life Science Systems Division of Brooks Automation. As well as serving as a Director on Carterra’s Board of Directors, he is currently the Executive Chairman of DYNEX Technologies and Agena Bioscience, serves on the Board of Directors of MANTA Instruments and COMPAS Software, and is CEO of IRORI Technologies. John Lillig has over 40 years’ experience in the management & guidance of clinical diagnostics & life science businesses and operations. VP and General Manager and with Amersham Pharmacia Biotech Inc., where he rose to President, Region North America and was responsible for sales, marketing, and customer support for all products sold in North America. Prior to that he was with Orchid Biosciences as Sr. He has also served as Chief Commercial Officer for Molecular Probes, Inc., the world leader in reagents for cell analysis, including flow cytometry consumables. Prior to Accuri Cytometers, he was CEO of Amnis Corporation, a venture backed technology start-up developing and selling high-end imaging flow cytometers. He and the management team sold the company to Becton Dickinson for $205M in March 2011. Most recently he was Chief Commercial Officer at Accuri Cytometers where he developed a novel commercialization model that was highly capital efficient. Ball has a long and proven record for bringing life science products to market and capitalizing on existing product potential. He sold ViroCyt and IntelliCyt in mid-2016 for $16M and $90M respectively as a former board member In addition, he serves on the board of directors of the following eight companies: Aquaro Biosystems where he is Executive Chairman, Celsee Diagnostics, DNA Software, ENT Biotech Solutions, NanoCellect, Swift Bioscience and Carterra. He is an Adjunct Professor at the University of Michigan, Ross Business School in Entrepreneurial Studies. He is President, Tyball Associates, LLC, a consulting company bringing 21st century sales and marketing strategies that are highly capital efficient, to companies in the biotech tools space. This technology is highly suited to the multicolor flow cytometry market. Jack Ball is CEO and a board member at Solulink, a San Diego biotech tools company supplying HybriLink™ technology that enables user attachment of fluorophores to antibodies in 30 minutes with no purification.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |